SohnX Hong Kong: Gabriel Grego of Quintessential Capital on why he’s short Cassava Sciences
The field of short-sellers has shrunk dramatically since the Department of Justice's probe was revealed earlier this year. However, some stalwart investors remain committed to the cause of unveiling potentially fraudulent companies.
Background On Cassava Sciences, Formerly Known As Pain Therapeutics
At the SohnX Hong Kong Conference, reputable short-seller Gabriel Grego of Quintessential Capital Management unmasked the individuals behind Cassava Sciences, previously known as Pain Therapeutics. He also explained why he sees problems at the company that has caused him to flag it as potentially fraudulent.
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
